This inventor holds 5 USPTO granted patents. Top assignees: University of Iowa Research Foundation, Children's Hospital, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1992-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Iowa City, IA (US) (1992 - 1995)
- North Liberty, IA (US) (1992 - 2008)
Company Filing History:
5 out of 925 
1 out of 25 
1 out of 3,696 
Years Active: 1992-2008
Title: Mark F Stinski: Innovator in Genetic Research
Introduction
Mark F Stinski is a prominent inventor based in North Liberty, Iowa, known for his significant contributions to genetic research. He holds a total of five patents, showcasing his innovative work in the field of molecular biology and gene therapy. His inventions focus on the development of nucleic acid molecules and vectors that have the potential to treat various genetic diseases.
Latest Patents
One of his latest patents is titled "Truncated CMV promoters and vectors containing same." This invention relates to nucleic acid molecules that comprise certain truncated forms of the human cytomegalovirus (CMV) immediate-early enhancer-promoter. These molecules can be operably linked to transgenes of interest, including those encoding partially-deleted CFTR proteins. The invention also includes vectors comprising these nucleic acid molecules and host cells transformed by such vectors. The applications of this invention are particularly relevant for treating a variety of genetic, metabolic, and acquired diseases, including cystic fibrosis (CF) airway disease.
Another notable patent is "Transfer vectors and microorganisms containing human cytomegalovirus." This patent discloses the cloning of a eukaryotic promoter-regulatory region that functions preferentially in human cells. The invention is exemplified by the cloning of a section of the human cytomegalovirus genome, which includes a DNA sequence with regulatory and promoter signals and an initiation site for RNA synthesis. This fragment, termed the human cytomegalovirus (HCMV) promoter-regulatory sequence, was obtained from purified HCMV DNA.
Career Highlights
Throughout his career, Mark F Stinski has worked with esteemed institutions such as the University of Iowa Research Foundation and Children's Hospital. His work has significantly advanced the understanding of gene therapy and the development of therapeutic vectors.
Collaborations
Mark has collaborated with notable colleagues, including Richard C Gehrz and Bruce I Kari, contributing to the advancement of genetic research and innovation.
Conclusion
Mark F Stinski's contributions to genetic research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for innovative treatments for genetic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile